LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: The Classroom of the Future

    Anna Tarabasz / Marko Selaković / Christopher Abraham

    Entrepreneurial Business and Economics Review, Vol 6, Iss 4, Pp 231-

    Disrupting the Concept of Contemporary Business Education

    2018  Volume 245

    Abstract: Objective: The goal of the article is to discuss and elaborate on the skillset required in education of managers and entrepreneurs to face challenges of their future positions. Research Design & Methods: The article is of a descriptive character, based ... ...

    Abstract Objective: The goal of the article is to discuss and elaborate on the skillset required in education of managers and entrepreneurs to face challenges of their future positions. Research Design & Methods: The article is of a descriptive character, based on literature review and its constructive criticism. It presents a case study of S P Jain School of Global Management in Dubai/Mumbai/Singapore/Sydney and experts’ insights. Findings: The classroom of the future, based on idea of design thinking lab, equipped with the most modern solutions of Virtual and Augmented Reality (VR, AR), interactive detachable workstations, shareable smartboards and interactive video display walls, seems to be the passport to success in the digital world. Immersive interaction with AI, ubiquitous computing and technology exposure prepare contemporary business students for future working space, encompassing a variety of problems to be solved, allowing to attain new skills and a smooth transit from education to a desired job or entrepreneurship practice. Implications & Recommendations: The creation of ‘future ready’ graduates requires an innovative mindset and agility to evolve and adapt continuously, with simultaneous focus on disruptive innovation through digital transformation. Incorporating latest digital technologies and innovations into the learning environment seems to be competitive advantage and the key to success on education market. Contribution & Value Added: The article in subsequent chapters lists the awaited skills of future entrepreneurs and managers, indicates available solutions and technologies to boost classroom experience and gives a practical example of technology use. Moreover, it indicates transformation pathway for business schools to embrace challenges of the future labour market and equip their graduates with hands-on experience and required skills.
    Keywords classroom of the Future ; business education ; economic education ; Social Sciences ; H
    Subject code 650
    Language English
    Publishing date 2018-12-01T00:00:00Z
    Publisher Cracow University of Economics
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article ; Online: Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)

    John Nikitas / Michael Roach / Cliff Robinson / Jeffrey Bradley / Jiayi Huang / Stephanie Perkins / Christina Tsien / Christopher Abraham

    Clinical and Translational Radiation Oncology, Vol 21, Iss , Pp 32-

    2020  Volume 35

    Abstract: Background: There is increasing interest in treating oligometastatic non-small cell lung cancer (NSCLC) patients with stereotactic radiation. We aimed to address whether patients definitively treated with synchronous thoracic stereotactic body radiation ... ...

    Abstract Background: There is increasing interest in treating oligometastatic non-small cell lung cancer (NSCLC) patients with stereotactic radiation. We aimed to address whether patients definitively treated with synchronous thoracic stereotactic body radiation therapy (SBRT) and brain stereotactic radiosurgery (SRS) had favorable outcomes with local therapy. Materials and methods: We reviewed a database of patients receiving lung SBRT as well as a database for brain metastasis patients treated with SRS between June 2004 and January 2016. We selected for cT1-2aN0M1 NSCLC patients with brain metastases and calculated their overall survival (OS), freedom from progression (FFP), and local control (LC) rates. Results: Six patients had oligometastatic NSCLC with 1–3 synchronous brain metastases treated with lung SBRT and brain SRS. No patients received immunotherapy and two-thirds did not receive systemic therapy. Median follow-up was 9 months for the entire cohort (range, 2–95 months) and 95 months for the surviving patient. Median OS was 12.4 months (95% confidence interval [CI], 7–18 months). At 1 year, patients had 67% OS (95% CI, 29–100%), 17% FFP (95% CI, 0–46%), and 100% LC. Their brain disease had 80% 1-year LC (95% CI, 45–100%) and 53% 1-year FFP (95% CI, 5–100%). Two patients had no distant progression, two had brain progression, one had adrenal gland progression, and one had bone and liver progression. Conclusion: In patients presenting with oligometastatic lung cancer limited to the brain, treatment with both lung SBRT and brain SRS achieves good LC of all sites with encouraging OS. Keywords: Lung cancer, Oligometastatic, Brain metastases, Stereotactic body radiation therapy, Stereotactic radiosurgery
    Keywords Medical physics. Medical radiology. Nuclear medicine ; R895-920 ; Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282
    Subject code 616 ; 610
    Language English
    Publishing date 2020-03-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  3. Article ; Online: A feasibility study to evaluate early treatment response of brain metastases one week after stereotactic radiosurgery using perfusion weighted imaging.

    Jiayi Huang / Mikhail Milchenko / Yuan J Rao / Pamela LaMontagne / Christopher Abraham / Clifford G Robinson / Yi Huang / Joshua S Shimony / Keith M Rich / Tammie Benzinger

    PLoS ONE, Vol 15, Iss 11, p e

    2020  Volume 0241835

    Abstract: Background To explore if early perfusion-weighted magnetic resonance imaging (PWI) may be a promising imaging biomarker to predict local recurrence (LR) of brain metastases after stereotactic radiosurgery (SRS). Methods This is a prospective pilot study ... ...

    Abstract Background To explore if early perfusion-weighted magnetic resonance imaging (PWI) may be a promising imaging biomarker to predict local recurrence (LR) of brain metastases after stereotactic radiosurgery (SRS). Methods This is a prospective pilot study of adult brain metastasis patients who were treated with SRS and imaged with PWI before and 1 week later. Relative cerebral blood volume (rCBV) parameter maps were calculated by normalizing to the mean value of the contralateral white matter on PWI. Cox regression was conducted to explore factors associated with time to LR, with Bonferroni adjusted p<0.0006 for multiple testing correction. LR rates were estimated with the Kaplan-Meier method and compared using the log-rank test. Results Twenty-three patients were enrolled from 2013 through 2016, with 22 evaluable lesions from 16 patients. After a median follow-up of 13.1 months (range: 3.0-53.7), 5 lesions (21%) developed LR after a median of 3.4 months (range: 2.3-5.7). On univariable analysis, larger tumor volume (HR 1.48, 95% CI 1.02-2.15, p = 0.04), lower SRS dose (HR 0.45, 95% CI 0.21-0.97, p = 0.04), and higher rCBV at week 1 (HR 1.07, 95% CI 1.003-1.14, p = 0.04) had borderline association with shorter time to LR. Tumors >2.0cm3 had significantly higher LR than if ≤2.0cm3: 54% vs 0% at 1 year, respectively, p = 0.008. A future study to confirm the association of early PWI and LR of the high-risk cohort of lesions >2.0cm3 is estimated to require 258 patients. Conclusions PWI at week 1 after SRS may have borderline association with LR. Tumors <2.0cm3 have low risk of LR after SRS and may be low-yield for predictive biomarker studies. Information regarding sample size and potential challenges for future imaging biomarker studies may be gleaned from this pilot study.
    Keywords Medicine ; R ; Science ; Q
    Subject code 616 ; 610
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Article ; Online: Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS)

    Christopher Abraham, MD / Adam Garsa, MD / Shahed N. Badiyan, MD / Robert Drzymala, PhD / Deshan Yang, PhD / Todd DeWees, PhD / Christina Tsien, MD / Joshua L. Dowling, MD / Keith M. Rich, MD / Michael R. Chicoine, MD / Albert H. Kim, MD, PhD / Eric C. Leuthardt, MD / Cliff Robinson, MD

    Advances in Radiation Oncology, Vol 3, Iss 2, Pp 146-

    2018  Volume 153

    Abstract: Objective: To identify potentially actionable dosimetric predictors of local control (LC) for non-small cell lung cancer (NSCLC) brain metastases treated with single-fraction stereotactic radiosurgery (SRS). Methods and materials: Patients with NSCLC ... ...

    Abstract Objective: To identify potentially actionable dosimetric predictors of local control (LC) for non-small cell lung cancer (NSCLC) brain metastases treated with single-fraction stereotactic radiosurgery (SRS). Methods and materials: Patients with NSCLC brain metastases treated with single-fraction SRS were identified. Eligible patients had at least 1 follow-up magnetic resonance imaging scan and were without prior metastasectomy or SRS to the same lesion. LC and overall survival (OS) were estimated using the Kaplan-Meier method. The Cox proportional hazards model was used for univariate (UVA) and multivariate analysis (MVA). Receiver operating characteristic (ROC) analysis was used to identify optimal cut points for dose-volume histogram metrics relative to LC. Results: A total of 612 NSCLC brain metastasis were identified in 299 patients with single-fraction SRS between 1999 and 2014. Median follow-up was 10 months. Median OS from time of SRS was 11 months. Overall LC was 75% and 66% at 1 and 2 years, respectively. On UVA, increasing dose by any measure was associated with improved LC. On MVA, volume receiving at least 32 Gy (V32; hazard ratio [HR], 0.069; P < .000), along with higher prescription isodose (HR, 0.953; P = .031) and lower volume (HR, 1.359; P < .000), were independent predictors of improved LC. ROC analysis demonstrated a V32 of 24% to be most predictive for LC. For the entire cohort, 1-year LC for V32 ≥24% was 89% versus 67% for V32 <24% (P = .000). Stratifying by volume, lesions ≤2 cm (n = 323) had a 1-year LC of 95% versus 82% (P = .005) for V32 above and below 24%, respectively. For lesions 2.1 to 3 cm (n = 211), 1-year LC was 79% versus 59% (P = .003) for V32 above and below 24%, respectively. Total tumor volume alone was predictive for OS. Conclusions: Volume, prescription isodose line, and V32 are independent predictors of LC. V32 represents an actionable SRS treatment planning parameter for NSCLC brain metastases.
    Keywords Medical physics. Medical radiology. Nuclear medicine ; R895-920 ; Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282
    Subject code 616
    Language English
    Publishing date 2018-04-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Article ; Online: Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents

    Sahaja Acharya, MD / Mustafaa Mahmood, BS / Daniel Mullen, DDS, MS / Deshan Yang, PhD / Christina I. Tsien, MD / Jiayi Huang, MD / Stephanie M. Perkins, MD / Keith Rich, MD / Michael Chicoine, MD / Eric Leuthardt, MD / Joshua Dowling, MD / Gavin Dunn, MD, PhD / Jesse Keller, MD / Clifford G. Robinson, MD / Christopher Abraham, MD

    Advances in Radiation Oncology, Vol 2, Iss 4, Pp 572-

    2017  Volume 580

    Abstract: Purpose: Stereotactic radiosurgery (SRS) in combination with immunotherapy (IMT) or targeted therapy is increasingly being used in the setting of melanoma brain metastases (MBMs). The synergistic properties of combination therapy are not well understood. ...

    Abstract Purpose: Stereotactic radiosurgery (SRS) in combination with immunotherapy (IMT) or targeted therapy is increasingly being used in the setting of melanoma brain metastases (MBMs). The synergistic properties of combination therapy are not well understood. We compared the distant intracranial failure rates of intact MBMs treated with SRS, SRS + IMT, and SRS + targeted therapy. Methods and materials: Combination therapy was defined as delivery of SRS within 3 months of IMT (anti-CTLA-4 /anti-PD-1 therapy) or targeted therapy (BRAF/MEK inhibitors). The primary endpoint was distant intracranial failure after SRS, which was defined as any new MBM identified on brain magnetic resonance imaging. Outcomes were evaluated using the Kaplan Meier method and Cox proportional hazards. Results: A total of 72 patients with melanoma with 233 MBMs were treated between April 2006 and April 2016. The number of MBMs within each treatment group was as follows: SRS: 121; SRS + IMT: 48; and SRS + targeted therapy: 64. The median follow-up was 8.9 months. One-year distant intracranial control rates for SRS, SRS + IMT, and SRS + targeted therapy were 11.5%, 60%, and 10%, respectively (P < .001). On multivariate analysis, after adjusting for steroid use and number of MBMs, SRS + IMT remained associated with a significant reduction in distant intracranial failure compared with SRS (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.29-0.80; P = .003) and compared with SRS + targeted therapy (HR, 0.41; 95% CI, 0.25-0.68; P = .001).One-year local control for SRS, SRS + IMT, and SRS + targeted therapy was 66%, 85%, and 72%, respectively (P = .044). On multivariate analysis, after adjusting for dose, SRS + IMT remained associated with a significant reduction in local failure compared with SRS alone (HR, 0.37; 95% CI, 0.14-0.95; P = .04). Conclusions: SRS with immunotherapy is associated with decreased distant and local intracranial failure compared with SRS alone. Prospective studies are warranted to validate this result.
    Keywords Medical physics. Medical radiology. Nuclear medicine ; R895-920 ; Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282
    Subject code 616
    Language English
    Publishing date 2017-10-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article ; Online: 5th International Symposium on Focused Ultrasound

    Menashe Zaaroor / Alon Sinai / Dorit Goldsher / Ayelet Eran / Maria Nassar / Ilana Schlesinger / Jonathon Parker / Vinod Ravikumar / Pejman Ghanouni / Sherman Stein / Casey Halpern / Vibhor Krishna / Amelia Hargrove / Punit Agrawal / Barbara Changizi / Eric Bourekas / Michael Knopp / Ali Rezai / Brian Mead /
    Namho Kim / Panagiotis Mastorakos / Jung Soo Suk / Wilson Miller / Alexander Klibanov / Justin Hanes / Richard Price / Shutao Wang / Oluyemi Olumolade / Tara Kugelman / Vernice Jackson-Lewis / Maria Eleni (Marilena) Karakatsani / Yang Han / Serge Przedborski / Elisa Konofagou / Kullervo Hynynen / Isabelle Aubert / Gerhard Leinenga / Rebecca Nisbet / Robert Hatch / Anneke Van der Jeugd / Harrison Evans / Jürgen Götz / Ann Van der Jeugd / Paul Fishman / Paul Yarowsky / Victor Frenkel / Shen Wei-Bin / Ben Nguyen / Carlos Sierra Sanchez / Camilo Acosta / Cherry Chen / Shih-Ying Wu / Muna Aryal / Iason T. Papademetriou / Yong-Zhi Zhang / Chanikarn Power / Nathan McDannold / Tyrone Porter / Zsofia Kovacs / Saejeong Kim / Neekita Jikaria / Farhan Qureshi / Michele Bresler / Joseph Frank / Henrik Odéen / George Chiou / John Snell / Nick Todd / Bruno Madore / Dennis Parker / Kim Butts Pauly / Mike Marx / Sumeeth Jonathan / William Grissom / Costas Arvanitis / Gregory Clement / Joshua de Bever / Allison Payne / Douglas Christensen / Guillaume Maimbourg / Mathieu David Santin / Alexandre Houdouin / Stéphane Lehericy / Mickael Tanter / Jean Francois Aubry / Christian Federau / Beat Werner / Dong-Guk Paeng / Zhiyuan Xu / Anders Quigg / Matt Eames / Changzhu Jin / Ashli Everstine / Jason Sheehan / M. Beatriz Lopes / Neal Kassell / James Drake / Karl Price / Lior Lustgarten / Vivian Sin / Charles Mougenot / Elizabeth Donner / Emily Tam / Mojgan Hodaie / Adam Waspe / Thomas Looi / Samuel Pichardo / Wonhye Lee / Yong An Chung / Yujin Jung / In-Uk Song / Seung-Schik Yoo / Hyun-Chul Kim / Jong-Hwan Lee / Charles Caskey / Wolf Zinke / Josh Cosman / Jillian Shuman / Jeffrey Schall / Christian Aurup / Hong Chen / Hermes Kamimura / Antonio Carneiro / Tao Sun / Navid Nazai / Sam Patz / Margaret Livingstone / Todd Mainprize / Yuexi Huang / Ryan Alkins / Martin Chapman / James Perry / Nir Lipsman / Allison Bethune / Arjun Sahgal / Maureen Trudeau / Hao-Li Liu / Po-Hung Hsu / Kuo-Chen Wei / Jonathan Sutton / Phillip Alexander / Eric Miller / Thiele Kobus / Alexandre Carpentier / Michael Canney / Alexandre Vignot / Kevin Beccaria / Delphine Leclercq / Cyril Lafon / Jean Yves Chapelon / Khe Hoang-Xuan / Jean-Yves Delattre / Ahmed Idbaih / David Moore / Alexis Xu / Paul Schmitt / Jessica Foley / Jonathan Sukovich / Charles Cain / Aditya Pandey / Neeraj Chaudhary / Sandra Camelo-Piragua / Steven Allen / Jon Cannata / Dejan Teofilovic / Jim Bertolina / Timothy Hall / Zhen Xu / Julien Grondin / Vincent Ferrera / Gail ter Haar / Petros Mouratidis / Elizabeth Repasky / Kelsie Timbie / Lena Badr / Benjamin Campbell / John McMichael / Andrew Buckner / Jessica Prince / Aaron Stevens / Timothy Bullock / Karin Skalina / Chandan Guha / Franco Orsi / Guido Bonomo / Paolo Della Vigna / Giovanni Mauri / Gianluca Varano / George Schade / Yak-Nam Wang / Venu Pillarisetty / Joo Ha Hwang / Vera Khokhlova / Michael Bailey / Tatiana Khokhlova / Ilya Sinilshchikov / Petr Yuldashev / Yulia Andriyakhina / Wayne Kreider / Adam Maxwell / Oleg Sapozhnikov / Ari Partanen / Jonathan Lundt / Tobias Preusser / Sabrina Haase / Mario Bezzi / Jürgen Jenne / Thomas Langø / Massimo Midiri / Michael Mueller / Giora Sat / Christine Tanner / Stephan Zangos / Matthias Guenther / Andreas Melzer / Arianna Menciassi / Selene Tognarelli / Andrea Cafarelli / Alessandro Diodato / Gastone Ciuti / Sven Rothluebbers / Julia Schwaab / Jan Strehlow / Senay Mihcin / Steffen Tretbar / Thomas Payen / Carmine Palermo / Steve Sastra / Kenneth Olive / Matthew Adams / Vasant Salgaonkar / Serena Scott / Graham Sommer / Chris Diederich / Joan Vidal-Jove / Eloi Perich / Antonio Ruiz / Manuela Velat / David Melodelima / Aurelien Dupre / Jeremy Vincenot / Chen Yao / David Perol / Michel Rivoire / Samantha Tucci / Lisa Mahakian / Brett Fite / Elizabeth Ingham / Sarah Tam / Chang-il Hwang / David Tuveson / Katherine Ferrara / Stephen Scionti / Lili Chen / Dusica Cvetkovic / Xiaoming Chen / Roohi Gupta / Bin Wang / Charlie Ma / Kenneth Bader / Kevin Haworth / Christy Holland / Narendra Sanghvi / Roy Carlson / Wohsing Chen / Christian Chaussy / Stefan Thueroff / Claudio Cesana / Carlo Bellorofonte / Qingguo Wang / Han Wang / Shengping Wang / Junhai Zhang / Alberto Bazzocchi / Alessandro Napoli / Robert Staruch / Chenchen Bing / Sumbul Shaikh / Joris Nofiele / Debra Szczepanski / Michelle Wodzak Staruch / Noelle Williams / Theodore Laetsch / Rajiv Chopra / Jarrett Rosenberg / Rachelle Bitton / Suzanne LeBlang / Joshua Meyer / Mark Hurwitz / Pavel Yarmolenko / Haydar Celik / Avinash Eranki / Viktoriya Beskin / Domiciano Santos / Janish Patel / Matthew Oetgen / AeRang Kim / Peter Kim / Karun Sharma / Alexander Chisholm / Dionne Aleman / Roberto Scipione / Michael Temple / Joao Guilherme Amaral / Ruby Endre / Maria Lamberti-Pasculli / Joost de Ruiter / Fiona Campbell / Jennifer Stimec / Samit Gupta / Manoj Singh / Sevan Hopyan / Gregory Czarnota / David Brenin / Carrie Rochman / Roussanka Kovatcheva / Jordan Vlahov / Katja Zaletel / Julian Stoinov / Matthew Bucknor / Viola Rieke / Jenny Shim / Korgun Koral / Brian Lang / Carlos Wong / Heather Lam / Alexander Shinkov / Jim Hu / Xi Zhang / Jonathan Macoskey / Kimberly Ives / Gabe Owens / Hitinder Gurm / Jiaqi Shi / Matthew Pizzuto / Christopher Dillon / Ivy Christofferson / Elaine Hilas / Jill Shea / Paul Greillier / Bénédicte Ankou / Francis Bessière / Ali Zorgani / Mathieu Pioche / Wojciech Kwiecinski / Julie Magat / Sandrine Melot-Dusseau / Romain Lacoste / Bruno Quesson / Mathieu Pernot / Stefan Catheline / Philippe Chevalier / Fabrice Marquet / Pierre Bour / Fanny Vaillant / Sana Amraoui / Rémi Dubois / Philippe Ritter / Michel Haïssaguerre / Mélèze Hocini / Olivier Bernus / Pamela Tebebi / Scott Burks / Blerta Milo / Michael Gertner / Jimin Zhang / Andrew Wong / Yu Liu / Azadeh Kheirolomoom / Jai Seo / Katherine Watson / Hua Zhang / Josquin Foiret / Alexander Borowsky / Doudou Xu / Maya Thanou / Miguell Centelles / Mike Wright / Maral Amrahli / Po-Wah So / Wladyslaw Gedroyc / Esther Kneepkens / Edwin Heijman / Jochen Keupp / Steffen Weiss / Klaas Nicolay / Holger Grüll / Matthew Nagle / Anastasia V. Nikolaeva / Marina E. Terzi / Sergey A. Tsysar / Bryan Cunitz / Pierre Mourad / Matthew Downs / Georgiana Yang / Qi Wang / Johnny Chen / Justin Farry / Adam Dixon / Zhongmin Du / Ali Dhanaliwala / John Hossack / Ashish Ranjan / Danny Maples / Rachel Wardlow / Jerry Malayer / Akhilesh Ramachandran / Hirofumi Namba / Motohiro Kawasaki / Masashi Izumi / Katsuhito Kiyasu / Ryuichi Takemasa / Masahiko Ikeuchi / Takahiro Ushida / Calum Crake / Satya V. V. N. Kothapalli / Wan Leighton / Zhaorui Wang / H. Michael Gach / William Straube / Michael Altman / Young-sun Kim / Hyo Keun Lim / Hyunchul Rhim / Johanna van Breugel / Manon Braat / Chrit Moonen / Maurice van den Bosch / Mario Ries / Cristina Marrocchio / Susan Dababou / Jae Young Lee / Hyun Hoon Chung / Soo Yeon Kang / Kook Jin Kang / Keon Ho Son / Dandan Zhang / Juan Plata / Peter Jones / Aurea Pascal-Tenorio / Donna Bouley / Aaron Bond / Robert Dallapiazza / Diane Huss / Amy Warren / Scott Sperling / Ryder Gwinn / Binit Shah / W. Jeff Elias / Colleen Curley / Ying Zhang / Karina Negron / Roger Abounader / Gesthimani Samiotaki / Tsang-Wei Tu / Georgios Papadakis / Dima Hammoud / Matthew Silvestrini / Frank Wolfram / Daniel Güllmar / Juergen Reichenbach / Denis Hofmann / Joachim Böttcher / Harald Schubert / Thomas G. Lesser / Scott Almquist / Francisco Camarena / Sergio Jiménez-Gambín / Noé Jiménez / Jin Woo Chang / Vandiver Chaplin / Rebekah Griesenauer / Michael Miga / Nicholas Ellens / Raag Airan / Alfredo Quinones-Hinojosa / Keyvan Farahani / Xue Feng / Samuel Fielden / Li Zhao / Max Wintermark / Craig Meyer / Sijia Guo / Xin Lu / Jiachen Zhuo / Su Xu / Rao Gullapalli / Dheeraj Gandhi / Omer Brokman / Hongchae Baek / Hyungmin Kim / Steven Leung / Taylor Webb / Natalia Vykhodtseva / Thai-Son Nguyen / Chang Kyu Park / Sang Man Park / Na Young Jung / Min Soo Kim / Won Seok Chang / Hyun Ho Jung / Michael Plaksin / Yoni Weissler / Shy Shoham / Eitan Kimmel / Pavel B. Rosnitskiy / Steve Krupa / Eilon Hazan / Omer Naor / Yoav Levy / Noam Maimon / Inbar Brosh / Itamar Kahn / Jessica Cahill / Elodie Constanciel Colas / Adrian Wydra / Roman Maev / Amirah Aly / Ozge Sesenoglu-Laird / Linas Padegimas / Mark Cooper / Barbara Waszczak / Seruz Tehrani / Craig Slingluff / James Larner / Kumari Andarawewa / Eugene Ozhinsky / Rutwik Shah / Roland Krug / Roel Deckers / Sabine Linn / Britt Suelmann / Arjen Witkamp / Paul Vaessen / Paul van Diest / Lambertus W. Bartels / Clemens Bos / Nicolas Borys / Gert Storm / Elsken Van der Wall / Navid Farr / Moez Alnazeer / Prateek Katti / Bradford Wood / Alexis Farrer / Cyril Ferrer / Baudouin Denis de Senneville / Marijn van Stralen / Jingfei Liu / J. Kent Leach / Stephan Zidowitz / Hsin-Lun Lee / Fang-Chi Hsu / Chia-Chun Kuo / Shiu-Chen Jeng / Tung-Ho Chen / Nai-Yi Yang / Jeng-Fong Chiou / Yi-tzu Kao / Chia-Hsin Pan / Jing-Fu Wu / Yi-Chieh Tsai / Sara Johnson / Dawei Li / Ye He / Ioannis Karakitsios / Michael Schwenke / Daniel Demedts / Xu Xiao / Ian Cavin / Emilee Minalga / Robb Merrill / Rock Hadley / Pascal Ramaekers / Martijn de Greef / Kian Shahriari / Mohammad Hossein Parvizi / Kiana Asadnia / Marzieh Chamanara / Seyed Kamran Kamrava / Hamid Reza Chabok / Ruben Stein / Sébastien Muller / Jeremy Tan / Cornel Zachiu / Hans-Peter Erasmus / Glen Van Arsdell / Lee Benson / Kee W. Jang / Mary Angstadt / Bobbi Lewis / Hailey McLean / Martijn Hoogenboom / Dylan Eikelenboom / Martijn den Brok / Pieter Wesseling / Arend Heerschap / Jurgen Fütterer / Gosse Adema / Kevin Wang / Pei Zhong / Joyce Joy / Helen McLeod / Harry Kim / Matthew Lewis / Arda Ozilgen / Peter Zahos / Dezba Coughlin / Xinyan Tang / Jeff Lotz / Kathleen Jedruszczuk / Amitabh Gulati / Stephen Solomon / Elena Kaye / John Mugler / Gaetano Barbato / Gian Luca Scoarughi / Cristiano Corso / Alessandro Gorgone / Ilaria Giuseppina Migliore / Zachary Larrabee / Arik Hananel / Jean-Francois Aubry / Ayele Negussie / Emmanuel Wilson / Reza Seifabadi / Hyungwon Moon / Jeeun Kang / Changbeom Sim / Jin Ho Chang / Hyuncheol Kim / Hak Jong Lee / Noboru Sasaki / Mitsuyoshi Takiguchi / Lukas Sebeke / Xi Luo / Bram de Jager / Maurice Heemels / Christopher Abraham / Laura Curiel / Rémi Berriet / Margit Janát-Amsbury / Joseph Corea / Patrick Peiyong Ye / Ana Clauda Arias / Micheal Lustig / Bryant Svedin

    Journal of Therapeutic Ultrasound, Vol 4, Iss S1, Pp 1-

    2016  Volume 113

    Keywords Medical physics. Medical radiology. Nuclear medicine ; R895-920
    Language English
    Publishing date 2016-11-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top